These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9186333)

  • 1. The safety of transurethral prostatectomy: a cohort study of mortality in 9,416 men.
    Cattolica EV; Sidney S; Sadler MC
    J Urol; 1997 Jul; 158(1):102-4. PubMed ID: 9186333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.
    Jeldres C; Isbarn H; Capitanio U; Zini L; Bhojani N; Shariat SF; Cloutier V; Lattouf JB; Duclos A; Jolivet-Tremblay M; Valiquette L; Saad F; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Aug; 182(2):626-32. PubMed ID: 19535100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia.
    Roos NP; Wennberg JE; Malenka DJ; Fisher ES; McPherson K; Andersen TF; Cohen MM; Ramsey E
    N Engl J Med; 1989 Apr; 320(17):1120-4. PubMed ID: 2469015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia: a population-based cohort study in Sweden.
    Chokkalingam AP; Nyrén O; Johansson JE; Gridley G; McLaughlin JK; Adami HO; Hsing AW
    Cancer; 2003 Oct; 98(8):1727-34. PubMed ID: 14534890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does transurethral resection of the prostate pose a risk to life? 22-year outcome.
    Koshiba K; Egawa S; Ohori M; Uchida T; Yokoyama E; Shoji K
    J Urol; 1995 May; 153(5):1506-9. PubMed ID: 7536257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: analysis of subjective changes, morbidity and mortality.
    van Melick HH; van Venrooij GE; Eckhardt MD; Boon TA
    J Urol; 2003 Apr; 169(4):1411-6. PubMed ID: 12629374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term incidence of acute myocardial infarction after open and transurethral resection of the prostate for benign prostatic hyperplasia.
    Shalev M; Richter S; Kessler O; Shpitz B; Fredman B; Nissenkorn I
    J Urol; 1999 Feb; 161(2):491-3. PubMed ID: 9915433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Bruskewitz R; Issa MM; Roehrborn CG; Naslund MJ; Perez-Marrero R; Shumaker BP; Oesterling JE
    J Urol; 1998 May; 159(5):1588-93; discussion 1593-4. PubMed ID: 9554360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
    Rosario DJ; Phillips JT; Chapple CR
    J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of serum acid phosphatase [correction of phosphate] elevation following transurethral prostatectomy on long-term mortality.
    O'Donnell PD; Lancaster SC
    J Ark Med Soc; 1992 Nov; 89(6):287-9. PubMed ID: 1385382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002).
    Vela-Navarrete R; Gonzalez-Enguita C; Garcia-Cardoso JV; Manzarbeitia F; Sarasa-Corral JL; Granizo JJ
    BJU Int; 2005 Nov; 96(7):1045-8. PubMed ID: 16225526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical outcomes for men undergoing laparoscopic radical prostatectomy after transurethral resection of the prostate.
    Jaffe J; Stakhovsky O; Cathelineau X; Barret E; Vallancien G; Rozet F
    J Urol; 2007 Aug; 178(2):483-7; discussion 487. PubMed ID: 17561162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endoscopic resection of benign prostatic hyperplasia in men over 80 years of age: a retrospective study of 184 cases].
    Chtourou M; Binous MY; Kbaier I; Hafsia G; Kallel Y; Horchani A
    Tunis Med; 2004 Aug; 82(8):725-9. PubMed ID: 15532766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinic analysis of repeat prostatectomy after transurethral prostatectomy for benign prostatic hyperplasia].
    Mao QZ; Rong S; Li HZ; Ji ZG; Xia M; Zang MF
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):372-4. PubMed ID: 15061986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
    Gupta N; Sivaramakrishna ; Kumar R; Dogra PN; Seth A
    BJU Int; 2006 Jan; 97(1):85-9. PubMed ID: 16336334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transurethral resection in prostatic cancer.
    Fujita K; Kimura T; Saito K; Sangen H; Furuhata T; Uyama K; Ogura K; Ueno F
    Clin Ther; 1988; 10 Spec No():12-5. PubMed ID: 2466566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of the safety and efficacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia.
    Tubaro A; Carter S; Hind A; Vicentini C; Miano L
    J Urol; 2001 Jul; 166(1):172-6. PubMed ID: 11435849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men.
    Ørsted DD; Bojesen SE; Nielsen SF; Nordestgaard BG
    Eur Urol; 2011 Oct; 60(4):691-8. PubMed ID: 21705134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction.
    Dotan ZA; Mor Y; Leibovitch I; Varon D; Golomb J; Duvdevani M; Ramon J
    J Urol; 2002 Aug; 168(2):610-3; discussion 614. PubMed ID: 12131319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of benign prostatic hyperplasia and occurrence of prostatic surgery and acute urinary retention: a population-based cohort study in the Netherlands.
    Souverein PC; van Riemsdijk MM; de la Rosette JJ; Opdam PC; Leufkens HG
    Eur Urol; 2005 Apr; 47(4):505-10. PubMed ID: 15774250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.